RxDoctor Payments Data

Ajit Deshmukh, MD

Adult Reconstructive Orthopaedic Surgery · Laurelton, NYNPI 1790002020

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (55.8%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 14 manufacturers reported payments, led by Intellijoint Surgical Inc. at 55.8% of the total. 2025 is the largest year on record at $4,609, more than ten times the $270 reported in 2019. That places this record below the midpoint for adult reconstructive orthopaedic surgery clinicians in NY, where the typical reported total is $11,547.

$7,175in general payments, 2019–2025

Across 28 payments — averaging $256.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intellijoint Surgical Inc.$4K
  • Smith+Nephew$1K
  • Stryker$893
  • Linkbio Corp$299
  • Exactech, Inc.$213
  • ERMI LLC$160
  • plus $386 from 8 others

What the payments were for

  • Consulting fees$4,00056%
  • Travel & lodging$1,74324%
  • Food & beverage$1,43220%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,175 in reported general payments places this provider in the 35th percentile of 85 adult reconstructive orthopaedic surgery providers in New York.

See all adult reconstructive orthopaedic surgery providers in New York

Medicare billing

Part B allowed, 2024
$216,238
Medicare patients
356
Services billed
12,713

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Diclofenac Sodium53$1,229
Pregabalin13$291
Celecoxib38$274
Meloxicam95$242
Pantoprazole Sodium53$232
Methylprednisolone16$168
Oxycodone Hcl26$103
Ibuprofen11$76
Tramadol Hcl28$55

Paid to pharmacies, not to this prescriber.

Other adult reconstructive orthopaedic surgery in Laurelton

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →